Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) EBIT Margin (2021 - 2026)

Bioceres Crop Solutions' EBIT Margin history spans 4 years, with the latest figure at 11.26% for Q1 2026.

  • On a quarterly basis, EBIT Margin fell 1984.0% to 11.26% in Q1 2026 year-over-year; TTM through Mar 2026 was 10.68%, a N/A change, with the full-year FY2025 number at 0.67%, down 1054.0% from a year prior.
  • EBIT Margin hit 11.26% in Q1 2026 for Bioceres Crop Solutions, down from 8.58% in the prior quarter.
  • Over the last five years, EBIT Margin for BIOX hit a ceiling of 8.58% in Q1 2025 and a floor of 77.68% in Q2 2022.
  • Historically, EBIT Margin has averaged 26.79% across 3 years, with a median of 11.26% in 2026.
  • Biggest five-year swings in EBIT Margin: skyrocketed 185346bps in 2022 and later plummeted -1984bps in 2026.
  • Tracing BIOX's EBIT Margin over 3 years: stood at 77.68% in 2022, then surged by 111bps to 8.58% in 2025, then tumbled by -231bps to 11.26% in 2026.
  • Business Quant data shows EBIT Margin for BIOX at 11.26% in Q1 2026, 8.58% in Q1 2025, and 77.68% in Q2 2022.